RECQL and breast cancer: The second study also observed that among 774 breast cancer patients, lower mRNA levels of RECQL were associated with poor distant recurrence-free survival (HR: 2.77, p-value <0.001) and disease-specific survival (HR: 3.10, p-value <0.001).